As the utilization of tyrosine is needed by both eukaryotes and prokaryotes, this versatile amino acid contributes towards a variety of operations including protein synthesis, pigment production, and host or habitat impacting metabolite creation. While there are numerous pathways which involve the degradation of tyrosine to create different products, the one that is central in this thesis is a pathway with homogentisate as an intermediate. This pathway brings an interest due to its association with metabolic disorders like Tyrosinemia (I, II, or III), and its impact within an agricultural environment. In other words, for humans and plant microbiomes to maintain their optimal metabolic homeostasis, tyrosine is required to participate in numerous demands. This necessity can ultimately create competition between organisms present in microbial communities, as there are a multitude of species that can metabolize tyrosine for the creation of diverse products. In this work, a primary objective is to characterize the breakdown of tyrosine within a competitive environment where there are multiple available pathways. There are many factors that could influence the catabolism of tyrosine like catalytic efficiency of enzymes, availability of breakdown routes, and pathway regulations. Here, the start will be creating a proof of concept developed by studying the competition for tyrosine utilization by environmental microbial enzymes; 4-hydroxyphenylpyruvate dioxygenase from Streptomyces avermitilis, 4-hydroxymandelate synthase from Amycolatopsis orientalis, and tyrosine ammonia lyase from Flavobacterium johnsoniae. Through phenotypic assays and by quantifying secreted metabolites, rerouting of this pathway is observed. This insight towards the ability of diverting the homogentisate pathway was then utilized for the analysis of contest between human enzyme, 4-hydroxyphenylpyruvate dioxygenase, and gut microbial enzyme, tyrosine ammonia lyase from Bacteroides ovatus. Within both aims it is seen that due to successful diversion of the pathway, there is a reduction in tyrosine with the formation of more favorable products. The strategy of redirecting this tyrosine catabolism pathway will provide baseline knowledge for future efforts to contribute towards alternative methods of intervention to alleviate the burdens from tyrosine metabolic dysfunction and disorders.